Withania somnifera — ashwagandha, also called Indian winter cherry or, loosely, “Indian ginseng” — is marketed for stress, sleep and general resilience, and it is sold as a standardised extract defined by its withanolide content. That single percentage carries an enormous amount of unstated assumption: which plant part the extract came from, which compounds the percentage actually counts, how those compounds were measured, and whether a divisive molecule called withaferin A is present, capped or stripped out. Two suppliers can print the same number and ship genuinely different products. This article unpacks what sits behind the figure.
What withanolides actually are
Withanolides are a family of naturally occurring steroidal lactones — C28 compounds built on an ergostane skeleton — that are characteristic of Withania somnifera and a handful of related Solanaceae. They are the marker class for ashwagandha: the compounds a “standardised” extract is standardised to. The family runs to dozens of individual molecules, the most discussed being withaferin A, withanolide A, withanolide B, withanone, and the withanosides (glycosylated withanolides such as withanoside IV and VI). A withanolide percentage is, in effect, a sum across some defined subset of this family — and which molecules are in that subset is precisely where extracts diverge.
It matters because the family is not chemically uniform. Withaferin A and withanone are concentrated differently across plant parts, behave differently in the body, and are detected differently by analytical methods. Treating “total withanolides” as a single interchangeable currency hides real compositional differences between products that share a label claim.
Why the percentage matters — and what it doesn’t tell you
The withanolide percentage is the headline specification: a 2.5% extract carries, by the relevant assay, 2.5 g of withanolides per 100 g of extract. Higher is not automatically better — it tells you concentration, not identity, and a higher number achieved by counting more compounds (or by including leaf-derived molecules) is not the same as a higher number from the same defined subset. The percentage answers “how much,” never “of what, from where, by which method.”
The withaferin-A question
No single compound shapes the ashwagandha market more than withaferin A. It is the most biologically potent withanolide and, for that reason, the most contentious. It is studied heavily in the literature, but its potency cuts both ways: the same reactivity that makes it pharmacologically interesting is associated, at higher levels, with tolerability and cytotoxicity concerns in cell models. This puts formulators of everyday supplements — marketed for stress and sleep rather than as actives in a therapeutic product — in a particular position.
Why some grades cap or remove it
Because withaferin A is concentrated in the leaf and present at much lower levels in the root, the plant part you start from largely determines how much you carry. Many premium supplement-grade extracts deliberately target a low or capped withaferin-A content, and some specify an upper limit (for example, withaferin A “not more than” a stated low percentage of total withanolides). The logic is that a stress or sleep supplement taken daily over months is formulated for a wide, self-selecting consumer base, and a high-potency, high-reactivity constituent is a liability to be controlled rather than a virtue to be maximised. Other grades — typically leaf-derived or whole-plant — carry more withaferin A by design, and are positioned differently.
Root vs leaf vs whole-plant — and why it matters
The plant part is arguably more decisive than the percentage. Traditional use of ashwagandha centres on the root, and most premium supplement-grade extracts are root-only by design. The leaf is richer in withanolides — which makes it an easy way to lift a percentage cheaply — but it carries a different, more withaferin-A-heavy profile and is not the part with the long traditional-use record. Whole-plant or aerial-part material sits in between and is often a sign that leaf has been blended in.
| Plant part | Typical withanolide level | Withaferin-A tendency | Typical positioning |
|---|---|---|---|
| Root only | Lower (often standardised to a modest %) | Naturally low; often capped or near-undetectable | Premium supplement grade; aligns with traditional use |
| Leaf | Higher (easy to push the % up) | Higher by nature of the plant part | Used to lift % cheaply; higher-reactivity profile |
| Whole-plant / aerial | Intermediate to high | Intermediate to high | Often signals leaf blended into root material |
The commercial consequence is blunt: a root-only claim with a low, capped withaferin-A level commands a different position from a percentage propped up by leaf. If a specification names only “Withania somnifera extract” and a percentage, the plant part is the first thing to pin down — because it silently determines the compound profile, the traditional-use story and the tolerability framing.
Major commercial extract types and how they differ
“Ashwagandha extract” spans several distinct product designs. They differ in plant part, in the marker they standardise to, and in extraction approach — and those differences, not the brand name, are what a specification should capture.
- Root-only, low-withanolide, withaferin-A-capped — the archetypal premium supplement grade, standardised to a modest total-withanolide percentage with withaferin A held to a low limit; positioned on root provenance and tolerability rather than headline potency.
- Root-and-leaf / full-spectrum — standardised to a higher withanolide percentage by drawing on both root and leaf; carries more withaferin A and is positioned on “potency” or “full spectrum.”
- Glycowithanolide-standardised — standardised specifically to the withanoside (glycosylated withanolide) fraction rather than total withanolides; a different marker definition that does not map one-to-one onto a “total withanolides” number.
- High-concentration / high-ratio — extracts pushed to high drug-to-extract ratios or high percentages, where the route to the number (plant part, marker subset) deserves particular scrutiny.
- Water-extracted vs hydroalcoholic — the solvent system shapes which withanolides are captured; water-based extraction is sometimes preferred for a cleaner solvent story, hydroalcoholic for broader withanolide recovery.
These are not interchangeable. A glycowithanolide-standardised grade and a total-withanolide grade are answering different questions, and comparing their percentages directly is a category error. The extract type, spelled out in full, is what makes two quotes genuinely comparable.
HPLC standardisation and the reference-standard problem
Modern ashwagandha extracts are standardised by HPLC (high-performance liquid chromatography), typically with UV detection, and increasingly by HPLC-MS or HPTLC for confirmation. The method separates the withanolides and quantifies them against reference standards — and that last step is where much of the ambiguity in the trade lives. A withanolide percentage is only as well-defined as the reference standards and the method used to generate it.
What the method has to settle
- Which compounds are counted — total withanolides as a sum of named markers, a single marker, or the glycowithanolide fraction; the answer changes the number for the same material.
- Which reference standards are used — pure, well-characterised standards for each counted withanolide are not uniformly available or affordable, so methods vary in how rigorously each compound is quantified.
- How unresolved peaks are handled — whether a “total withanolides” figure is a true sum of identified compounds or a broader gravimetric/colorimetric estimate that overstates specificity.
- Wavelength and conditions — withanolides are quantified at defined UV wavelengths; differences in method conditions move the result and make cross-supplier numbers hard to compare.
Common quality and adulteration issues
Ashwagandha’s popularity and the gap between cheap leaf and premium root make it a target for the usual botanical quality problems. Most resolve to one question: is the number real, and does it describe the material you think you are buying?
- Leaf substitution in “root” extracts — leaf or aerial material blended into a root claim to lift the withanolide percentage cheaply; betrayed by an unexpectedly high withaferin-A level for a root grade.
- Spiking and inflated assays — withanolide figures propped up by non-specific methods, or by isolated/synthetic withaferin A added to hit a percentage that the botanical did not deliver.
- Wrong or mixed species — adulteration with related or unrelated species; identity confirmation (botanical and, where used, DNA or HPTLC fingerprint) guards against it.
- Method-mismatched numbers — a percentage from a generous, non-specific assay presented as if it were a validated HPLC figure, so two “5%” grades are not measuring the same thing.
- Excipient and carrier loading — high carrier content diluting the actual extract, or undeclared maltodextrin shifting what the percentage is calculated against.
- Residue and contaminant gaps — solvent residues, heavy metals and microbial limits not addressed, which matter as much as the marker for a daily-use ingredient.
How to specify an ashwagandha grade
A defensible ashwagandha specification never stops at a percentage. It pins down the four variables that actually determine what arrives: the marker (and its definition), the method, the plant part, and the solvent — plus the withaferin-A position and the standard contaminant limits. Write these into the specification and the COA, and most of the ambiguity above disappears.
- 1Marker and percentage — state the withanolide marker exactly: “total withanolides” (and which compounds are summed), a single named marker, or the glycowithanolide fraction, with the target percentage and tolerance.
- 2Method — require a named, validated analytical method (e.g. withanolides by validated HPLC at a defined wavelength), not just “by HPLC,” and ask which reference standards it runs against.
- 3Plant part — specify root-only, root-and-leaf, or whole-plant explicitly; do not accept a bare “Withania somnifera extract.”
- 4Withaferin-A position — set an upper limit where a low-reactivity, root-aligned grade is intended (for example, withaferin A “not more than” a stated value), or specify it deliberately where a higher level is wanted.
- 5Solvent / extraction — name the solvent system (water, hydroalcoholic, defined ratio) and the drug-to-extract ratio, since both shape the withanolide profile.
- 6Carrier and identity — declare any carrier/excipient and the basis the percentage is calculated on, and require botanical identity confirmation (and fingerprint where used).
- 7Safety limits — specify heavy metals, residual solvents, pesticide and microbial limits, which are part of the grade, not an afterthought.
Apply this to your sourcing
Share your specifications — we’ll respond within 24 hours.